Related Experiment Video
Updated: Aug 17, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
The role of c-Jun in the AP-1 activation induced by naturally occurring isothiocyanates
1Department of Chemoprevention, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Abstract:
Despite strong evidence that isothiocyanates (ITCs) inhibit cancer development, there are also reports that some of them induce or promote carcinogenesis. The molecular basis of the latter is largely unknown. We report here that all three ITCs that caused urinary bladder cancer in rats, including allyl ITC, benzyl ITC, and phenethyl ITC, increased the transactivation of activator protein 1 (AP-1) and AP-1 DNA binding in human bladder cancer UM-UC-3 cells. Amongst all Fos and Jun family members examined, only were the levels of c-Jun and Fra-2 consistently elevated by the ITCs. However, whereas c-Jun was identified as the predominant component in the AP-1 DNA binding complex, Fra-2 was not detected, suggesting that c-Jun may be mainly responsible for ITC-induced AP-1 activation. c-Jun was also induced by the ITCs in other bladder cancer cell lines (both human and rat) and by their N-acetylcysteine derivatives--their main urinary metabolites. c-Jun induction by the ITCs appears to involve both transcriptional activation and protein phosphorylation; the latter resulted from activation of c-Jun N-terminal kinase by the ITCs. Because c-Jun has been implicated in cancer development, including human bladder cancer, our data suggest that c-Jun activation may play an important role in ITC-induced bladder carcinogenesis.
Insights
Certain isothiocyanates (ITCs) may promote bladder cancer by activating c-Jun. This study identifies c-Jun activation as a key mechanism in isothiocyanate-induced bladder carcinogenesis, offering insights into cancer promotion.
Area of Science:
- Oncology
- Molecular Biology
- Carcinogenesis
Background:
- Isothiocyanates (ITCs) show mixed effects on cancer, with some inhibiting and others potentially promoting carcinogenesis.
- The molecular mechanisms underlying ITC-induced carcinogenesis are not well understood.
Purpose of the Study:
- To investigate the molecular basis of how certain ITCs induce or promote bladder cancer.
- To identify the specific molecular pathways involved in ITC-induced bladder carcinogenesis.
Main Methods:
- Utilized human bladder cancer cell lines (UM-UC-3) and rat bladder cancer cell lines.
- Assessed the transactivation and DNA binding of activator protein 1 (AP-1) in response to ITCs.
- Examined the expression levels of Fos and Jun family members, focusing on c-Jun and Fra-2.
- Investigated the role of c-Jun N-terminal kinase (JNK) in ITC-induced c-Jun activation.
Main Results:
- Allyl ITC, benzyl ITC, and phenethyl ITC increased AP-1 transactivation and DNA binding in human bladder cancer cells.
- c-Jun and Fra-2 levels were elevated by ITCs, with c-Jun identified as the predominant component in the AP-1 DNA binding complex.
- ITC-induced c-Jun was observed in various human and rat bladder cancer cell lines and their metabolites.
- ITC exposure activated c-Jun through transcriptional activation and protein phosphorylation, involving JNK activation.
Conclusions:
- c-Jun activation plays a significant role in the bladder carcinogenesis induced by certain ITCs.
- The findings suggest that c-Jun activation is a key molecular mechanism underlying ITC-induced bladder cancer promotion.
Related Concept Videos
Caspases
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Cell Specific Gene Expression
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
